In this report, we have identified overexpression of the oncogene, TRIB2, as a potential mediator of acquired in vivo resistance to Cisplatin in SCLC, the first report of such overexpression being linked to Cisplatin resistance. The gene discussed is TRIB2; the disease is small cell lung carcinoma.